Contact Us: 01282 426380
KM Financial Solutions | Chinese biotech firm Ascletis raises $400 mln in HK IPO – sources
23633
post-template-default,single,single-post,postid-23633,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Chinese biotech firm Ascletis raises $400 mln in HK IPO – sources

25 Jul Chinese biotech firm Ascletis raises $400 mln in HK IPO – sources

Posted at 02:12h in News by
0 Likes
Chinese biotech Ascletis
Pharma Inc raised $400 million after pricing its
initial public offering (IPO) in the middle of an indicative
range, three sources said, in the first such Hong Kong listing
under new rules designed to attract early-stage biotech firms.

No Comments

Sorry, the comment form is closed at this time.